Medicure (MCUJF) Free Cash Flow Growth (1y) (2010 - 2026)
Medicure (MCUJF) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 90.13 Bn | 88.27 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 10.34% |
| 3 | Zoetis | 32.59 Bn | 30.65 Bn | 1.62 Bn | -13.65% |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | 56.40% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | -5.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -29.32% |
| 8 | Neurocrine Biosciences | 17.80 Bn | 16.48 Bn | 800.70 Mn | 166.91% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 44.93% |
| 10 | Medicure | 8.77 Mn | 7.64 Mn | 2.57 Mn | -391.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -391.09% |
| Dec 31, 2025 | -98.61% |
| Sep 30, 2025 | 33.19% |
| Jun 30, 2025 | -2,298.67% |
| Mar 31, 2025 | 566.70% |
| Dec 31, 2024 | 142.75% |
| Sep 30, 2024 | -296.04% |
| Jun 30, 2024 | -104.97% |
| Mar 31, 2024 | -176.55% |
| Sep 30, 2023 | -71.74% |
| Jun 30, 2023 | -61.18% |
| Mar 31, 2023 | 122.02% |
| Sep 30, 2022 | -40.20% |
| Jun 30, 2022 | 205.24% |
| Mar 31, 2022 | -428.31% |
| Sep 30, 2021 | 206.03% |
| Jun 30, 2021 | 153.21% |
| Mar 31, 2021 | 128.87% |
| Dec 31, 2020 | 68.21% |
| Sep 30, 2020 | 119.86% |